Nephron Recalls Succinylcholine Chloride Injection Due to Incorrect Labeling
Nephron Pharmaceuticals is recalling 19,390 syringes of Succinylcholine Chloride Injection because of incorrect or missing lot and expiration dates.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III and involves a documentation/labeling issue (missing or incorrect lot/exp dates) without reported injuries or illnesses, which aligns with the 'Low' severity criteria for packaging or documentation problems.
Plain-English summary
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center is recalling 19,390 syringes of PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL). The affected product is distributed in single-dose containers containing five 10 mL pre-filled syringes. The recall covers lots SU9079A and SU9079B, which have an expiration date of 4/5/2020.
The recall was initiated due to incorrect or missing lot and/or expiration date labeling. The product was distributed nationwide in the United States.
Healthcare providers and consumers should stop using the affected product and contact Nephron Pharmaceuticals for further instructions.
The recalled product
- Product
- PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, 5 x 10 mL pre-filled syringes, Nephron 503B Outsourcing Facility 4500 12th St. Ext West Columbia, SC 29172, NDC 69374-919-10.
- Category
- Drug — Injection
- Hazard
- Affected units
- 19,390
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lots: SU9079A
- SU9079B
- Exp 4/5/2020
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
See all →- SevereNephron Recalls Fentanyl and Ropivacaine Injection Due to Glass Contamination
FDA (Drugs) · 2019-10-30
- SevereNephron Recalls Fentanyl and Bupivacaine Injection Due to Glass Contamination
FDA (Drugs) · 2019-10-30
- SevereNephron Amino Acid Injection Recalled for Sterility and Leak Concerns
FDA (Drugs) · 2019-10-30
- SevereNephron Recalls Fentanyl and Bupivacaine Injection Due to Glass Contamination
FDA (Drugs) · 2019-10-30
- SevereNephron Recalls del Nido Cardioplegia Solution Due to Sterility Concerns
FDA (Drugs) · 2019-10-30
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- HighSuccinylcholine Chloride Injection Recalled for Sterility Assurance Failure
FDA (Drugs) · 2022-07-27
- HighSuccinylcholine Chloride Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2022-06-08
- LowUS Compounding Recalls Succinylcholine Chloride Injection Due to Labeling Error
FDA (Drugs) · 2021-01-20
- HighNephron Phenylephrine HCl Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-27
- HighPhenylephrine HCl Injection Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-06-08
- HighPhenylephrine HCl injection recalled for lack of sterility assurance
FDA (Drugs) · 2022-07-27